-

Daiwa Health Development Introduces Ground-Breaking Brain Supplement

GARDENA, Calif.--(BUSINESS WIRE)--Daiwa Health Development, the U.S. subsidiary of the prominent Japanese brand Daiwa Pharmaceutical Co., Ltd., announced today that it has developed a new ground-breaking supplement to support brain health.

The new product, called "Daiwa Brain Health®," includes Hokkaido Scallop Oil Plasmalogen (HSOP™) as its key ingredient, which has been scientifically shown to improve memory and sharpen cognitive function.

"Daiwa Brain Health® is a major breakthrough in brain health supplementation," said Nori Shirai, executive director of Daiwa Pharmaceutical Co., Ltd., the parent company of Daiwa Health Development. "This product contains the brand-new ingredient plasmalogen to support optimal brain health."

The supplement is based on several scientific studies that demonstrate the effectiveness of plasmalogen, a type of phospholipid found in high concentrations in the brain, for reducing cognitive decline and improving memory.

For example, a major 2019 study by seven scientists in the Journal of Alzheimer's Disease & Parkinsonism examined 157 patients aged 60-85 with "moderate-to-severe Alzheimer's Disease" and found that those supplemented with plasmalogen (Pls) experienced a significant improvement in cognitive function.

"Orally administered scallop-derived Pls improve cognitive function and that the measurement of blood Pls is valuable to assess the severity and treatment progress in patients with moderate-to-severe A.D.," the study concluded.

Another study, published in the Japanese Pharmacology and Therapeutics, studied the impact of food with plasmalogen on patients aged 50-80 with memory complaints. The study found that "daily supplementation of plasmalogen may improve the cognitive function in the older population aged above 60 years."

Both studies were placebo-controlled and double-blind, making them some of the most reliable studies on plasmalogen to date. Placebo-controlled is when neither the researcher nor the participant knows who is receiving the treatment, and double-blind means that neither the participant nor the researcher knows which group is getting the placebo.

Daiwa shares three other major research papers published in international, peer-reviewed journals on the benefits of plasmalogen, including EBioMedicine, Lipids, and another in the Journal of Alzheimer's Disease & Parkinsonism.

"The science behind plasmalogen is clear," said Shirai. "This key ingredient can improve memory and cognitive function, which is why we've included it in our new Daiwa Brain Health® supplement."

Daiwa Brain Health® is now available for purchase on the company's website and Amazon.

About Daiwa Health Development

Daiwa Health Development is the U.S. branch of Daiwa Pharmaceutical Co., Ltd., a leading Japanese manufacturer and marketer of health supplements for more than three decades. Based in California, the company's mission is to develop and provide innovative, high-quality health supplements that support optimal health and well-being.

It's also the manufacturer of several other top-selling items in the United States, including Plasmanex1 and BRM4, doctor-approved supplements to improve blood circulation and boost the immune system, respectively.

What makes Daiwa's supplements different is the use of high-quality, science-backed, natural ingredients that are often not found in other supplements. Daiwa says independent researchers from prestigious institutions such as Oxford University, Cambridge University, and the University of California Los Angeles provide input and expert advice to the company's product development team.

The company is also known for its commitment to quality control, adhering to the FDA's Food Safety Modernization Act (FSMA) regulations, the most stringent in the industry. Daiwa says it conducts research at a world-class level with dozens of dedicated staff members focused on developing products that are safe, effective, and backed by science.

"Nature is a powerful force," reads Daiwa's mission statement. "It can provide us with everything we need to live long and healthy lives. We've harnessed this power by creating nutritional supplements that help people lead healthier and happier lifestyles."

"We don't just produce these products on an industrial scale; they are made in small batches from natural ingredients in our facilities. We are constantly innovating to provide our customers with the best possible products. We're always looking for ways to better serve their needs."

For more information about this ground-breaking supplement or other Daiwa products, please visit the company's website or contact us at info@dhdmed.com or 310-329-2362.

** The above statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Daiwa Health Development does not provide medical advice, diagnosis, or treatment. Consult with your medical doctor prior to taking any supplement.

Contacts

Hank Cheatham
Vice President – Sales & Marketing
(310) 329-2362
hcheatham@dhdusa.net

Daiwa Health Development


Release Summary
Daiwa Health Development Introduces Ground-Breaking Brain Supplement - Hokkaido Scallop Oil Plasmalogen (HSOP™) as its key ingredient.
Release Versions

Contacts

Hank Cheatham
Vice President – Sales & Marketing
(310) 329-2362
hcheatham@dhdusa.net

Social Media Profiles
More News From Daiwa Health Development

Daiwa Health Development, Inc. Announces Webinar with Dr. Fred Pescatore on RBAC’s Clinical Applications

LOS ANGELES--(BUSINESS WIRE)--Daiwa Health Development, Inc. is excited to announce an upcoming webinar featuring Dr. Fred Pescatore, a renowned integrative medicine expert. The webinar will be held on August 29, 2024, at 1 p.m. (PST) / 2 p.m. (MST) / 4 p.m. (EST), and will delve into the clinical applications of RBAC (Rice Bran Arabinoxylan Compound), Daiwa’s patented ingredient that is integral to one of their flagship products. As Daiwa Health Development celebrates over 30 years of dedicati...

Daiwa Health Development Launches New Product to Support Digestive Health

GARDENA, Calif.--(BUSINESS WIRE)--Daiwa Health Development, a leading provider of natural health and wellness products, announces the launch of its new product, Daiwa GastroImmune™. Powered by ImmunoLin®, this dietary supplement helps support digestive function and a healthy mucosal immune system. ImmunoLin® is an agglomerated powder purified from edible bovine plasma that contains more than 50% immunoglobulins, other peptides and growth factors found naturally in milk or colostrum. Proteomics...

Daiwa Health Development to Present Top Products at Webinar

GARDENA, Calif.--(BUSINESS WIRE)--Dr. Fred Pescatore M.D. MPH, will explain how bacillopeptidase F. can help tackle metabolic disorders in a safe, non-invasive manner....
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.